share_log

Hempacco Receives Notification of Deficiency From Nasdaq

Hempacco Receives Notification of Deficiency From Nasdaq

Hempacco 收到納斯達克的缺陷通知
newsfile ·  04/23 22:00

San Diego, California--(Newsfile Corp. - April 23, 2024) - Hempacco Co., Inc. (NASDAQ: HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on April 18, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Annual Report").

加利福尼亞州聖地亞哥--(Newsfile Corp.-2024 年 4 月 23 日)- Hempacco Co., Inc.(納斯達克股票代碼:HPCO) 垂直整合的大麻製造公司(“Hempacco” 或 “公司”)今天宣佈,它於2024年4月18日收到了納斯達克股票市場(“納斯達克”)上市資格部門的書面通知(“通知”),表明該公司沒有遵守納斯達克上市規則5250(c)(1)(“規則”),因爲該公司尚未提交10-K表的年度報告截至2023年12月31日的財政年度(“年度報告”)。

The Rule requires listed companies to file all required periodic reports with the Securities and Exchange Commission in a timely manner. The Notice does not immediately affect the listing or trading of the Company's securities. However, if the Company fails to regain compliance with the Rule in a timely manner, the Company's securities will be subject to delisting from Nasdaq. Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice or until June 18, 2024, to submit a plan to regain compliance with the Rule. If Nasdaq accepts the Company's plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the Form 10-K or until October 14, 2024, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.

該規則要求上市公司及時向證券交易委員會提交所有必要的定期報告。該通知不會立即影響公司證券的上市或交易。但是,如果公司未能及時恢復對該規則的遵守,該公司的證券將被從納斯達克退市。根據納斯達克的規定,公司自收到通知之日起或直到2024年6月18日有60個日曆日的時間提交恢復遵守該規則的計劃。如果納斯達克接受公司的計劃,那麼納斯達克可以批准自10-K表格的到期日起最多180個日曆日或直到2024年10月14日的例外情況,以恢復合規。但是,無法保證納斯達克會接受公司恢復合規的計劃,也無法保證公司能夠在納斯達克批准的任何延期內恢復合規。如果納斯達克不接受該公司的計劃,那麼公司將有機會向納斯達克聽證小組對該決定提出上訴。

The Company is working diligently to complete and file the Annual Report and regain compliance with the Rule.

公司正在努力完成和提交年度報告,並重新遵守該規則。

About Hempacco

關於 Hempacco

Hempacco Co., Inc.'s goal is Disrupting Tobacco's $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables, vapes, and rolling paper. Hempacco owns The Real Stuff functional hemp cigarette and rolling paper brand. In addition, Hempacco manufactures a wide range of CBD-based nutraceutical and beauty products and various gummy products at its 50,000-sf cGMP facility in San Diego.

Hempacco., Inc. '其目標是通過製造和銷售香草、香料和大麻素可吸食物、電子煙和捲紙,用香草和大麻類的尼古丁香菸替代品顛覆菸草業的1萬億美元產業。Hempacco 擁有 Real Stuff 功能性大麻香菸和捲紙品牌。此外,Hempacco在其位於聖地亞哥的5萬平方英尺的cGMP工廠生產各種基於CBD的營養品和美容產品以及各種軟糖產品。

Hempacco's operational segments include:

Hempacco 的運營部門包括:

  1. Manufacturing of vapes, hemp smokables, and hemp rolling papers

  2. Manufacturing of cosmetics and nutraceutical products

  3. Functional Mushroom product development using patented solubility technology

  4. Celebrity-branded gummies and smokable products from Rick Ross, Cheech & Chong, and Snoop Dogg.

  1. 電子煙、大麻煙霧和大麻捲紙的製造

  2. 化妝品和營養品的製造

  3. 使用專利溶解度技術開發功能性蘑菇產品

  4. 來自 Rick Ross、Cheech & Chong 和 Snoop Dogg 的名人品牌軟糖和可吸菸產品。

For investor inquiries, please contact:
Sandro Piancone, CEO
Investor Relations: ir@hempaccoinc.com
619-779-0715

投資者如有查詢,請聯繫:
首席執行官桑德羅·皮安科內
投資者關係:ir@hempaccoinc.com
619-779-0715

Safe Harbor Statement

安全港聲明

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "SEC") by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

本新聞稿包含前瞻性陳述。此外,我們或我們的代表可能會不時以口頭或書面形式發表前瞻性陳述。我們將這些前瞻性陳述建立在我們對未來事件的預期和預測的基礎上,這些預期和預測來自我們目前獲得的信息。此類前瞻性陳述與未來事件或我們的未來表現有關,包括:我們的財務業績和預測;我們的收入和收益增長;以及我們的業務前景和機會。您可以識別那些非歷史性陳述的前瞻性陳述,尤其是那些使用 “可能”、“應該”、“期望”、“預期”、“考慮”、“估計”、“相信”、“計劃”、“預測”、“預測”、“潛力” 或 “希望” 等術語或這些術語或類似術語的否定詞的陳述。在評估這些前瞻性陳述時,您應考慮各種因素,包括:(i) 可能無法實現預期的發展和相關目標;(ii) 可能影響我們產品和業務的適用法律或法規的變化;(iii) COVID-19 疫情對公司及其當前或預期市場的影響;(iv) 本文描述的其他風險和不確定性,以及其他報告和其他公開文件中不時討論的風險和不確定性證券交易委員會(該公司的 “SEC”)。這些因素和其他因素可能導致我們的實際業績與任何前瞻性陳述存在重大差異。前瞻性陳述只是預測。本新聞稿中討論的前瞻性事件以及我們或我們的代表不時發表的其他陳述可能不會發生,實際事件和結果可能存在重大差異,並受有關我們的風險、不確定性和假設的影響。我們沒有義務公開更新或修改任何前瞻性陳述,無論是由於不確定性和假設,本新聞稿中討論的前瞻性事件以及我們或我們的代表不時發表的其他陳述都可能不會發生。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論